Pinsent Masons announces new leadership for Global IP Group and Life Sciences

10 Sep 2024 | 03:51 pm | 1 min. read

Pinsent Masons has appointed Judith Krens (Partner, Amsterdam) and Tom Nener (Partner, Birmingham) as co-leads of the Global Intellectual Property (IP) team, and has appointed Charlotte Weekes (Partner, London) as Head of Life Sciences. The appointments come in light of the upcoming departure of Clare Tunstall, the current Head of IP and Life Sciences, who will be leaving the firm in the Autumn.

Jim Cormack (Global Head of Risk Advisory Services), Pinsent Masons, said: "These new appointments reflect the strength and diversity of our global IP and life sciences practice. Judith, Tom and Charlotte are outstanding lawyers with proven track records of delivering excellent service to our clients across a range of sectors and jurisdictions. They have the vision, skills and experience to lead our teams and drive our strategy in these key areas of our business."

"We would also like to thank Clare for her contribution to the firm. She has played a key role in the growth of our IP and Life Sciences practice and we wish her all the best for the future."

Biographies:

Judith Krens joined Pinsent Masons in 2022 as a partner in the Amsterdam office, where she heads the IP practice. She is a leading patent litigator with extensive experience in complex cross-border patent disputes and LS regulatory disputes.  She is also a UPC representative and litigates in the UPC. She advises clients in various sectors, including life sciences, technology, and consumer goods.

Tom Nener joined Pinsent Masons in 2019 and became a partner in the Birmingham office in 2022, where he co-led our international Brand Protection and Creative Rights team. He is a recognised expert in IP litigation with a focus on brand protection, creative rights and trade secrets. He acts for clients in a range of industries, such as technology, sports, retail and consumer, manufacturing and automotive.

Charlotte Weekes joined Pinsent Masons in 2010 and became a partner in the London office in 2015, where she is a member of the IP team and previously led the Generics & Biosimilars Focus Group. She is a specialist in life sciences having advised clients in the sector for more than 20 years. Charlotte’s background is in life sciences patent and Supplementary Protection Certificate litigation, regularly co-ordinating pan-EU strategies to support clients bringing products to market or seeking to maintain their market position.

Key Contacts

Jim Cormack KC

Jim Cormack KC

Partner, Head of Risk Advisory Services

View Profile
Judith Krens

Judith Krens

Partner, Co-Head of Intellectual Property

View Profile
Tom Nener

Tom Nener

Partner, Co-Head of Intellectual Property

View Profile
Charlotte Weekes

Charlotte Weekes

Partner, Head of Life sciences

View Profile

Latest press releases

Show me all press releases

Pinsent Masons advises on highest value bonus claim brought before DIFC Court

Multinational law firm Pinsent Masons has successfully represented Mr. Ferri-Ricchi, a foreign exchange trader, in what is believed to be the highest value bonus claim ever brought before the Dubai International Financial Centre Court of First Instance.

Pinsent Masons hires pensions expert

Multinational law firm Pinsent Masons has appointed pensions partner, Ian Mylrea, to join the firm’s financial services sector in Manchester

Pinsent Masons signs lease to move to iconic Sydney address

Multinational law firm Pinsent Masons will continue its strong growth in Australia at a new Sydney address after signing a lease to move into one of the city’s most iconic addresses.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises medtech startup OASYS NOW as it reaches significant milestone

Multinational law firm Pinsent Masons has advised Netherlands-based MedTech startup OASYS NOW on its journey to receive its first equity investment.

Pinsent Masons advises Clarios on Series B1 financing round of Altris

Multinational law firm Pinsent Masons advised Clarios on its investment in Altris as part of the Series B1 financing round.

Pinsent Masons announces FY23/24 results

Multinational law firm Pinsent Masons has unveiled its 2023/24 year end results, announcing a 7.2% revenue increase to £649.6m as it continues to develop its cross border, sector-led capabilities prioritising investment into its people, client service and communities.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.